MRI-Guided Real-Time Adaptive Radiotherapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 November 2024 | Viewed by 1488
Special Issue Editor
2. Department of Medical, Surgical and Health Care Specialties, University of Brescia, 25121 Brescia, Italy
Interests: MRI-guided radiation therapy; stereotactic body radiotherapy; cancer
Special Issue Information
Dear Colleagues,
Radiation therapy is a crucial part of cancer treatment, where a multi-disciplinary approach is the standard of care. The advances in Radiation Oncology are continuous due to the innovations in engineering, imaging, physics, and technology, along with improvements in the knowledge of the radiobiology of cancer and healthy tissues.
Precision radiotherapy is the new paradigm of this non-invasive cancer treatment; over the last years, the concrete evolution in intensity-modulated adaptive radiotherapy was the clinical integration in the treatment room of online MRI with external beam radiotherapy. The advantages of MRI over CT-based images are well known and include higher soft tissue discrimination, the capability to monitor tumor motion, and the possibility of real-time treatment adaptation strategies. All these abilities allow operators to check and correct the inter- and intrafraction modifications in tumors, surrounding organs shape, and anatomical positioning. MRI-based physiologic information and biomarkers could potentially be utilized and integrated in an advanced-precision radiation therapy strategy: the outcome assessment using image texture represents the emerging world called "radiomics". The integration of MRI imaging capabilities with modern linear accelerators represents a paradigm shift in radiation therapy due to the opportunity to use the real-time anatomic and physiologic changes in tumors and surrounding critical organs to optimize the therapeutic ratio.
In this Special Issue, we will evaluate and report on all these aspects.
I look forward to receiving your contributions.
Prof. Dr. Filippo Alongi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiotherapy
- MRI-guided radiation therapy
- stereotactic body radiotherapy
- cancer
- radiation oncology
